InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the full record of transactions filed by Fowler Neal Franklin. Director active across 2 companies, notably Aralez Pharmaceuticals Inc.. Aggregated, 5 disclosures have been recorded. Split: 0 buy · 1 sell. Total volume traded: €187k. Activity tracked since 3 October 2023. The latest transaction was filed on 30 April 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Fowler Neal Franklin is a declarant linked to Emergent BioSolutions Inc. and Aralez Pharmaceuticals Inc., where he is a director. Across 5 filings in total, the sampled recent filings run from 2016-02-09 to 2025-05-02 and show EUR 0 in buys and EUR 186959 in sells, with the dominant transaction nature listed as Attribution.